HomeLatestSci Fi or Sci fact: Will Neural Implants Replace VR Headsets?
Sci Fi or Sci fact: Will Neural Implants Replace VR Headsets?
December 28, 2021 - by Kevin Flynn
Science fiction is a genre of unlimited imagination, but it’s not fantasy. The great Sci-Fi writers of the twentieth century introduced us to strange new worlds and unbelievable technologies. Those weren’t made up out of thin air. Asimov, Heinlein, Bradbury, and Roddenberry did their research. Most of those ideas were based in real scientific principles.
What was once science fiction has become science fact. Great authors of days gone by are sometimes credited with shaping the development of new technology, yet the lessons they taught us are easily forgotten. It’s time to revisit them. Neural implants, one of the more controversial topics during the golden age of sci-fi, are in the news this week.
Elon Musk Claims Neuralink will Replace VR Headsets
With great power comes great responsibility. Unfortunately, Elon Musk does not adhere to that credence. His latest pronouncement that “Neuralink will replace VR headsets” is self-serving propaganda issued without a care for potential consequences. The science of neural implants is too new and his “pig presentation” was nothing more than smoke and mirrors.
Neuralink is not a public company. I’d invest in them if they were, for the medical implications of the tech, not gamer fantasies. As for Elon Musk, Tesla stock dropped $300 a share in November after his stock sell-off announcement. Motor Trend shut him out in both the car and truck categories this year. Like them, I put my money on Rivian (RIVN) and Lucid (LCID).
Despite overwhelming resources and a global public platform for promotion, Musk could not push Neuralink past the finish line in the race for first FDA approval. That honor went to Synchron. Their brain-computer interface device was approved for human trials in July. Unfortunately, they are also not a public company.
On December 23rd, 2021, Phillip O’Keefe, a 62-year-old afflicted with ALS, used Synchron’s “Stentrode” neural implant to send the first ever thought-generated message on social media. Mark the date. The technology works. We’re years away from mass adoption, but now is the time to start having a conversation about its limits. Stay tuned for more on that.
Amouranth Joins Metaverse Playboy Mansion
Mark Zuckerberg doesn’t care about Elon Musk’s opinions. His metaverse acquired a major partner in early December when Playboy announced they’d be building a virtual “Playboy Mansion” and a service called “Centerfold” that will compete with Only Fans. Cardi B threw her weight behind it early. Now, Twitch icon Amouranth has joined the party.
Like it or not, sex sells. Playboy Group Inc (PLBY) hasn’t performed well in December, but they are up 140% on the year. This deal to develop a virtual property with Meta Platforms (FB), could be the “virtual ED med” they need to exceed expectations in 2022. The Twitch connection with Amouranth could give Amazon (AMZN) a boost too, as if they need it.
Using neural implants to live full-time in virtual reality is still science fiction. The tools are there, but don’t expect to have access to them any time soon. Elon Musk is a great showman, not a reliable source. Mark Zuckerberg knows how to build what the masses want and he’s doing it right now. In the short-term, he’ll dominate the space.
Share this article:
Disclaimer
This communication was produced by Prism MarketView. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PRISM” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PRISM see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy…
This communication was produced by Prism MarketView, “PRISM”. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PRISM, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.
“PRISM” and its affiliates are not a registered or licensed broker, dealer, broker-dealer, investment adviser nor investment manager, nor does “PRISM” engage in any activities that would require such registrations. “PRISM” and its affiliates do not provide investment advice, endorsement, analysis or recommendations with respect to any securities, and its services to or statements about its clients should never be construed as any endorsement of or opinion about any security of any client. No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other similar product or service regardless of whether such security, product, or service is referenced in this communication.
Our articles, reports/releases and videos are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We only publish favorable information because we are compensated to publish only favorable information. We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest.
This communication may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, market conditions, regulatory developments, and other factors beyond the control of the profiled company. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. PRISM undertakes no obligation to update or revise any such statements.
The contributors may buy and sell securities before, during and after any particular article, report and publication. In no event shall “PRISM” or affiliates be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by “PRISM”, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages.Further, nothing in this communication is intended to provide tax, legal, or investment advice and nothing in this communication should be construed as a recommendation to buy, sell or hold any investment or security or to engage in any investment strategy or transaction. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. Never invest in any stock featured by “PRISM” and its affiliates unless you can afford to lose your entire investment.We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and investment advisers. An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. We encourage our readers to invest carefully and read the investor information available at the web sites of the U.S. Securities and Exchange Commission (SEC) at www.sec.gov and the Financial Industry Regulatory Authority (FINRA) at www.finra.org.
FuelCell Energy, Inc. (NASDAQ: FCEL), a clean energy technology company that manufactures utility-scale fuel cell power systems, is set to…
About the Author:
Kevin Flynn
A former financial professional and founder of AdvisorScale Financial Writing, Kevin lives in Leominster, Massachusetts with his wife Evelyn, two cats, and nine wonderful grandchildren.
